Astra Investors Split On Pfizer Rejection
Some shareholders in the UK company preferred an opportunity to consider higher bid, while others backed the board's longer term view to stay independent
Source
AstraZeneca may have released outdated information on its COVID-19 vaccine trial, US health officials say. The Data and Safety Monitoring Board said in a statement Tuesday that it was concerned that AstraZeneca may have provided an incomplete view of the efficacy data for its vaccine. AstraZeneca reported Monday that its vaccine provided strong protection among adults of all ages, a finding that could help move it a step closer to clearance for use in the U.S. Ref. USAToday.
News about people dying after being vaccinated is no encouragement for people already doubtful about taking any vaccine.